Eligible AACR 2019 Annual Meeting Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Plenary Session 3: Germline Determinants of Therapeutic Efficacy and Toxicity

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Overview
Margaret R. Spitz, M.D.
UT M.D. Anderson Cancer Ctr., Houston, TX
from 2006 Molecular Diagnostics in Cancer Therapeutic Development conference on September 13, 2006 4:15 PM-6:30 PM
Relevance of Cytochrome P450 Polymorphisms to Anticancer Drugs
William P. Petros, Pharm.D.
West Virginia University Health Sciences Center, Morgantown, WV
from 2006 Molecular Diagnostics in Cancer Therapeutic Development conference on September 13, 2006 4:15 PM-6:30 PM
Individual Determinants of Vaccine Therapy
John J. Nemunaitis, M.D.
Mary Crowley Medical Research Center, Dallas, TX
from 2006 Molecular Diagnostics in Cancer Therapeutic Development conference on September 13, 2006 4:15 PM-6:30 PM
Case History: The First Drug-Specific FDA-Approved Pharmacogenetic Test: UGT1A1 Genotyping for Irinotecan
Mark J. Ratain, M.D.
University of Chicago, Chicago, IL
from 2006 Molecular Diagnostics in Cancer Therapeutic Development conference on September 13, 2006 4:15 PM-6:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4